Product NDC: | 63323-970 |
Proprietary Name: | BENZTROPINE MESYLATE |
Non Proprietary Name: | BENZTROPINE MESYLATE |
Active Ingredient(s): | 1 mg/mL & nbsp; BENZTROPINE MESYLATE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-970 |
Labeler Name: | Fresenius Kabi USA, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA090233 |
Marketing Category: | NDA |
Start Marketing Date: | 20110531 |
Package NDC: | 63323-970-02 |
Package Description: | 5 VIAL in 1 BOX (63323-970-02) > 2 mL in 1 VIAL |
NDC Code | 63323-970-02 |
Proprietary Name | BENZTROPINE MESYLATE |
Package Description | 5 VIAL in 1 BOX (63323-970-02) > 2 mL in 1 VIAL |
Product NDC | 63323-970 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | BENZTROPINE MESYLATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20110531 |
Marketing Category Name | NDA |
Labeler Name | Fresenius Kabi USA, LLC |
Substance Name | BENZTROPINE MESYLATE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anticholinergic [EPC],Antihistamine [EPC],Cholinergic Antagonists [MoA],Histamine Receptor Antagonists [MoA] |